Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Pharma’s Path to Adopting AI and Other Emerging Technologies

Posted on February 7th, 2018 by

Pharma R&D

create-3026190_1920

Right now in the pharmaceutical space, emerging technologies are dominating the conversation. As the cost of drug development soars, and the potential for success seems more and more elusive, the industry is pinning its hopes on promising technological breakthroughs. Continue reading “Pharma’s Path to Adopting AI and Other Emerging Technologies” »

Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference

Posted on January 19th, 2018 by

Pharma R&D

frequency-309372_1280

The 2018 J.P. Morgan Healthcare Conference, held in San Francisco from January 8-11, came and went in a whirlwind. Continue reading “Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference” »

Translational Medicine, Data Access and Pharmaceutical Innovation

Posted on January 17th, 2018 by

Pharma R&D

translational medicine

Some of the early seeds of translational medicine were planted in 1992 when the U.S. National Cancer Institute introduced a program designed to improve and accelerate the knowledge exchange between basic and clinical science. Continue reading “Translational Medicine, Data Access and Pharmaceutical Innovation” »

A Hackathon Demonstrates the Need for Deep Learning in R&D

Posted on January 12th, 2018 by

Pharma R&D

binary-2372130_1920

Today’s life science companies find themselves dealing with an interesting dilemma. With the help of many technological breakthroughs, they now have access to tons of data bursting with potential. Continue reading “A Hackathon Demonstrates the Need for Deep Learning in R&D” »

Companies and Investors Gather in San Francisco for J.P. Morgan Healthcare Conference January 8-11

Posted on January 9th, 2018 by

Pharma R&D

san-francisco-51002_1280

Healthcare companies and investors are flocking to San Francisco from January 8-11 for the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel. Continue reading “Companies and Investors Gather in San Francisco for J.P. Morgan Healthcare Conference January 8-11” »

Solving Global Research Challenges with Artificial Intelligence

Posted on January 8th, 2018 by

Pharma R&D

board-1364652_1280

In the 21st century, we are facing a number of enormous global challenges. Simply producing enough food and clean water to nourish the planet’s growing population is one of the biggest difficulties. Meanwhile, we must also deal with the ravages of climate change and take on medical problems like antibiotic resistance. Continue reading “Solving Global Research Challenges with Artificial Intelligence” »

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 55


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.